Danielle Lauzon is a partner in Goodwin’s Technology and Life Sciences groups, co-chair of the Life Sciences M&A practice, and leader of the firm’s Business Law department in Boston.

Danielle advises privately-held and publicly-traded companies across the company life-cycle, including formation and founder matters, venture capital and growth equity financings, public offerings, mergers and acquisitions, joint ventures, carve-out transactions, SEC compliance and corporate governance.  In addition, Danielle represents venture capital and private equity firms in connection with their investments in emerging growth and later-stage companies. Danielle’s practice focuses on the life sciences and healthcare sectors, including biotechnology, medical devices, digital health, healthcare IT, health & wellness and women’s health.

Danielle acts as co-chair of Goodwin’s PropSci practice which is focused on supporting the intersection of life sciences and real estate by providing clients integrated and innovative services that adapt along with their needs.